Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3488 Malignant insulinomas - Are they all alike?

Introduction: Insulinomas are the most common functional pNET. Its malignant variant has a frequency

Conference:

Presenting Author:

Authors: Barrio Löwer Daniele M, León N, Belli S, Moncet D, O'Connor J,

Keywords: insulinoma, pNET, malignant insulinoma, neuroendocrine tumor,

#3071 Hormonal Ectopic Secretion Syndromes Associated to Neuroendocine Neoplasia

Introduction: Neuroendocrine neoplasias (NEN) are able to produce and secrete bioactive peptides and cause distinct syndromes related to their biological effects. The outcome will depend on the oncological disease as well as the hormonal syndrome

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Belli S

Authors: Belli S, Tkatch J, O'Connor J, Martinez M, Paissan A,

Keywords: ectopic secretion, hormonal syndrome, neuroendocrine neoplasia,

#1848 Liver Metastatic Disease (LMD) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): Incidence, Treatment and Survival in a Multicenter Study in Argentina. Preliminary Report. ARGENTUM GROUP

Introduction: The first observational Study from our Group in Argentina, showed 60% incidence of liver mets at initial diagnosis. The treatment encompasses a wide scope of surgical and non-surgical modalities.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: O´Connor J

Authors: O'Connor J, Sanchez Loria F, Fauda M, Montal S, Podestá G,

Keywords: Liver, NETs,

#1764 Use of Tyrosine-Kinase Inhibitors in Medullary Thyroid Carcinoma: An Institutional Experience

Introduction: Medullary thyroid cancer (MTC) comprises 4% of thyroid tumors. 7-23% of patients (pts) have metastases at diagnosis. In some cases metastatic disease follows an indolent course, and in others it progresses rapidly, requiring systemic treatment. Tyrosine-kinase inhibitors (TKI) have demonstrated a median progression-free survival (PFS) of 11 months.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Luca R

Authors: Luca R, O'Connor J, Falco A, Do Pico F, Tsou F,

Keywords: TNE, TKI,

#1406 Collision Tumor of the Appendix: Mucinous Cystadenoma and Carcinoid. A Case Report

Introduction: Mucinous cystadenoma is the most common of benign neoplasms of the appendix and carcinoid is the most common type of primary malignant lesions of the appendix.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: OConnor J

Authors: Pombo T, O'Connor J, Dominichini E, Belli S, Pesce V,

Keywords: collision tumor, appendix tumor,